Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety and pharmacokinetics of AD-116 and AD-1161 in healthy adult male subjects. Benign prostatic hyperplasia is listed as the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• AD-116
• AD-1161

Snippet

Sponsor: Addpharma Inc. | Conditions: Benign Prostatic Hyperplasia | Phase 1 | Status: RECRUITING